Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus

Diabetes Metab Res Rev. 2012 Mar;28(3):284-8. doi: 10.1002/dmrr.2261.

Abstract

Background: Increased plasma activity of gamma-glutamyltransferase (GGT) is associated with cardiovascular diseases (CVD) and mortality in the general population. We investigated the association between GGT, CVD and mortality in individuals with diabetes mellitus.

Methods: Data used were from 1280 participants, aged 35-70 years, with a confirmed diagnosis of diabetes mellitus in the European Prospective Investigation into Cancer and Nutrition in Potsdam (Germany), Bilthoven and Utrecht (the Netherlands). Multivariate hazard ratios (HR) and 95% confidence intervals (CI) for CVD (non-fatal and fatal events) and overall mortality were estimated using sex-specific quartiles of GGT.

Results: After 8.2 years follow-up, 108 incident CVD cases and 84 deaths were observed. Participants with high GGT activity had an increased mortality risk: HR in the highest quartile was 3.96 (95% CI 1.74, 9.00). This association was in particular present in former and current smokers, younger persons and those with a higher waist-height ratio and alcohol consumption. No associations were observed for non-fatal CVD and non-fatal and fatal CVD events combined.

Conclusions: Higher GGT plasma activity is associated with increased all-cause mortality in individuals with diabetes.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / mortality*
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / mortality*
  • Female
  • Follow-Up Studies
  • Germany / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Risk Factors
  • Smoking / mortality
  • Waist Circumference
  • gamma-Glutamyltransferase / blood*

Substances

  • gamma-Glutamyltransferase